No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Dasatinib
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
-
Leukemia, Myeloid, Chronic-Phase*
-
Protein Kinase Inhibitors / pharmacology
-
Protein-Tyrosine Kinases
Substances
-
Imatinib Mesylate
-
Protein Kinase Inhibitors
-
Protein-Tyrosine Kinases
-
Dasatinib